Last reviewed · How we verify
topiramate; almotriptan malate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
topiramate; almotriptan malate (topiramate; almotriptan malate) — Janssen-Ortho LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| topiramate; almotriptan malate TARGET | topiramate; almotriptan malate | Janssen-Ortho LLC | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- topiramate; almotriptan malate CI watch — RSS
- topiramate; almotriptan malate CI watch — Atom
- topiramate; almotriptan malate CI watch — JSON
- topiramate; almotriptan malate alone — RSS
Cite this brief
Drug Landscape (2026). topiramate; almotriptan malate — Competitive Intelligence Brief. https://druglandscape.com/ci/topiramate-almotriptan-malate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab